Suppr超能文献

铜/锌超氧化物歧化酶的过表达可保护转基因小鼠免受早期糖尿病性肾小球损伤。

Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice.

作者信息

Craven P A, Melhem M F, Phillips S L, DeRubertis F R

机构信息

Dpartment of Medicine, VA Medical Center and University of Pittsburgh, Pittsburgh, Pennsylvania 15240, USA.

出版信息

Diabetes. 2001 Sep;50(9):2114-25. doi: 10.2337/diabetes.50.9.2114.

Abstract

Ex vivo and in vitro observations implicate superoxide as a mediator of cell injury in diabetes, but in vivo evidence is lacking. In the current studies, parameters of glomerular injury were examined in hemizygous nondiabetic transgenic mice (SOD) and streptozotocin-diabetic (D) transgenic mice (D-SOD), which overexpress human cytoplasmic Cu2+/Zn2+ superoxide dismutase (SOD-1), and in corresponding wild-type littermates (WT, D-WT) after 4 months of diabetes. In both SOD and D-SOD mice, renal cortical SOD-1 activity was twofold higher than values in the WT mice; blood glucose and glycosylated hemoglobin (GHb) levels did not differ in the two diabetic groups. Urinary albumin excretion, fractional albumin clearance, urinary transforming growth factor-beta (TGF-beta) excretion, glomerular volume, glomerular content of immunoreactive TGF-beta, and collagen alpha1 (IV) and renal cortical malondialdehyde (MDA) levels were significantly higher in D-WT mice compared with corresponding values in D-SOD mice. Glomerular volume, glomerular content of TGF-beta and collagen IV, renal cortical MDA, and urinary excretion of TGF-beta in D-SOD mice did not differ significantly from corresponding values in either the nondiabetic SOD or WT mice. In separate groups of mice studied after 8 months of diabetes, mesangial matrix area, calculated as a fraction of total glomerular tuft area, and plasma creatinine were significantly higher in D-WT but not in D-SOD mice, compared with corresponding values in the nondiabetic mice. In vitro infection of mesangial cells (MC) with a recombinant adenovirus encoding human SOD-1 increased SOD-1 activity threefold over control cells and prevented the reduction of aconitase activity, an index of cellular superoxide, and the increase in collagen synthesis that otherwise occurred in control MC in response to culture with 300 or 500 mg/dl glucose. Thus, increases in cellular SOD-1 activity attenuate diabetic renal injury in vivo and also prevent stimulation of MC matrix protein synthesis induced in vitro by high glucose.

摘要

体外和体内观察表明,超氧化物是糖尿病中细胞损伤的介质,但缺乏体内证据。在当前研究中,对4个月糖尿病后的半合子非糖尿病转基因小鼠(SOD)和链脲佐菌素诱导的糖尿病转基因小鼠(D)(D-SOD)进行了肾小球损伤参数检查,这些小鼠过度表达人细胞质Cu2+/Zn2+超氧化物歧化酶(SOD-1),并对相应的野生型同窝小鼠(WT,D-WT)进行了检查。在SOD和D-SOD小鼠中,肾皮质SOD-1活性比WT小鼠的值高两倍;两个糖尿病组的血糖和糖化血红蛋白(GHb)水平没有差异。与D-SOD小鼠的相应值相比,D-WT小鼠的尿白蛋白排泄、白蛋白清除率、尿转化生长因子-β(TGF-β)排泄、肾小球体积、免疫反应性TGF-β的肾小球含量、胶原蛋白α1(IV)和肾皮质丙二醛(MDA)水平显著更高。D-SOD小鼠的肾小球体积、TGF-β和胶原蛋白IV的肾小球含量、肾皮质MDA以及TGF-β的尿排泄与非糖尿病SOD或WT小鼠的相应值没有显著差异。在糖尿病8个月后研究的另一组小鼠中,与非糖尿病小鼠的相应值相比,D-WT小鼠的系膜基质面积(以肾小球毛细血管丛总面积的分数计算)和血浆肌酐显著更高,但D-SOD小鼠中没有。用编码人SOD-1的重组腺病毒体外感染系膜细胞(MC),使SOD-1活性比对照细胞增加了两倍,并防止了乌头酸酶活性的降低(细胞超氧化物的指标)以及胶原蛋白合成的增加,否则对照MC在与300或500mg/dl葡萄糖培养时会发生这种情况。因此,细胞SOD-1活性的增加在体内减轻糖尿病肾损伤,并且还防止了高糖在体外诱导的MC基质蛋白合成的刺激。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验